Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in Patients With Untreated Aplastic Anemia

Active, not recruitingOBSERVATIONAL
Enrollment

36

Participants

Timeline

Start Date

May 10, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

June 30, 2027

Conditions
Aplastic Anemia
Trial Locations (1)

920-0934

Kanazawa University, College of Medical Pharmaceutical and Health Sciences, School of Medicine, Department of Hematology, Kanazawa

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY